Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_675375ae4f084b4875d36afff6059afd |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
filingDate |
2017-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e838144e35253e1775862cbfe87de28a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c40e227b54d1255b95d3f07bc7a29f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cbab7606f3da63e50b236a9300ce413 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b913b8bbf157e8b04ce145c518e1454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_150105ee0adabf6977a70402991a950e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82b9d00400db04cf8292456f3ee96972 |
publicationDate |
2018-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018165865-A1 |
titleOfInvention |
Crystal forms of 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-phenylamino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone |
abstract |
A plurality of free base crystal forms of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-phenylamino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone and preparation methods therefor; further provided are the pharmaceutical formulations containing the crystal forms and a use thereof in the treatment of diseases, in particular in the treatment of angiogenic eye diseases. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113024439-A |
priorityDate |
2017-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |